Literature DB >> 24912841

TIGIT safeguards liver regeneration through regulating natural killer cell-hepatocyte crosstalk.

Jiacheng Bi1, Xiaodong Zheng, Yongyan Chen, Haiming Wei, Rui Sun, Zhigang Tian.   

Abstract

UNLABELLED: Overactivation of innate immunity, particularly natural killer (NK) cells, is harmful to liver regeneration; however, the molecular mechanisms that limit NK cell overactivation during liver regeneration are still elusive. Here we show that a coinhibitory receptor, T cell Ig and ITIM domain (TIGIT), was selectively up-regulated on NK cells, along with high expression of its ligand, poliovirus receptor (PVR/CD155), on hepatocytes during liver regeneration. The absence of TIGIT impaired liver regeneration in vivo, along with overactivation of NK cells and higher NK-derived interferon-gamma (IFN-γ) production. We also show that both depletion of NK cells and deficiency of IFN-γ, but not deficiency of RAG1, rescued impaired liver regeneration caused by the absence of TIGIT. Adoptive transfer of Tigit(-/-) NK cells into NK-deficient Nfil3(-/-) mice sufficiently led to impairment of liver regeneration. On the other hand, silencing PVR in hepatocytes rescued impaired liver regeneration caused by TIGIT deficiency in vivo, while blockade of TIGIT in NK-hepatocyte coculture increased IFN-γ production by NK cells in vitro.
CONCLUSION: TIGIT is a safeguard molecule to improve liver regeneration through negatively regulating NK-hepatocyte crosstalk. This finding suggests a novel mechanism of NK cell self-tolerance towards regenerative hyperplasia of the host.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24912841     DOI: 10.1002/hep.27245

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  26 in total

Review 1.  Balancing natural killer cell activation through paired receptors.

Authors:  Ludovic Martinet; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

Review 2.  Roles of natural killer cells in immunity to cancer, and applications to immunotherapy.

Authors:  Natalie K Wolf; Djem U Kissiov; David H Raulet
Journal:  Nat Rev Immunol       Date:  2022-05-30       Impact factor: 108.555

3.  Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T Cells.

Authors:  Gráinne Jameson; Cathal Harmon; Rhyla Mae Santiago; Diarmaid D Houlihan; Tom K Gallagher; Lydia Lynch; Mark W Robinson; Cliona O'Farrelly
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

4.  CD155 expression impairs anti-PD1 therapy response in non-small cell lung cancer.

Authors:  Chang Jiang; Xiaodie Qu; Li Ma; Ling Yi; Xu Cheng; Xiang Gao; Jinghui Wang; Nanying Che; Hongtao Zhang; Shucai Zhang
Journal:  Clin Exp Immunol       Date:  2022-06-11       Impact factor: 5.732

Review 5.  Insights Into Human Intrahepatic NK Cell Function From Single Cell RNA Sequencing Datasets.

Authors:  Gráinne Jameson; Mark W Robinson
Journal:  Front Immunol       Date:  2021-03-22       Impact factor: 7.561

Review 6.  Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.

Authors:  Cheng Sun; Hao-yu Sun; Wei-hua Xiao; Cai Zhang; Zhi-gang Tian
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

7.  Hepatectomy leads to loss of TRAIL-expressing liver NK cells via downregulation of the CXCL9-CXCR3 axis in mice.

Authors:  Takuya Yano; Masahiro Ohira; Ryosuke Nakano; Yuka Tanaka; Hideki Ohdan
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

8.  Modulation of liver regeneration via myeloid PTEN deficiency.

Authors:  Wen-Tao Ma; Yan-Jie Jia; Qing-Zhi Liu; Yan-Qing Yang; Jing-Bo Yang; Zhi-Bin Zhao; Zhen-Ye Yang; Qing-Hua Shi; Hong-Di Ma; M Eric Gershwin; Zhe-Xiong Lian
Journal:  Cell Death Dis       Date:  2017-05-25       Impact factor: 8.469

Review 9.  Liver natural killer cells: subsets and roles in liver immunity.

Authors:  Hui Peng; Eddie Wisse; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2015-12-07       Impact factor: 11.530

Review 10.  Immune cells in liver regeneration.

Authors:  Na Li; Jinlian Hua
Journal:  Oncotarget       Date:  2017-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.